UnitedHealth Group's third-quarter earnings beat estimates with revenues of $100.8 billion and earnings of $7.15 per share, but its guidance disappointed investors.
Despite posting solid earnings growth and expanding services in Optum Health and Optum Rx, regulatory pressures from Medicare Advantage have created reimbursement headwinds.
Collection
[
|
...
]